Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pruthi

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Journal of Endourology|September 18, 2014
Robotic ureteral reconstruction distal to the ureteropelvic junction: a large single institution clinical series with short-term follow upGordon L Fifer, Mathew C Raynor, Patrick Selph, et al.
Urologic Oncology|July 7, 2009
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?Raj Kurpad, William Kim, W Kim Rathmell, et al.
BJU International|January 22, 2010
A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological resultsRaj S Pruthi, Matthew Nielsen, Samuel Heathcote, et al.
Urology|March 9, 2022
Virtual "Matchmaking": Stakeholder Perspectives on the Future of the Urology Residency MatchChristopher J Warren, Chanan R Reitblat, Charles A Ferreri, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Urology Practice|August 18, 2023
Advanced Practice Providers in U.S. Urology: A National Survey of Demographics and Clinical RolesJoshua P Langston, Venetia L Orcutt, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Journal of Endourology|September 18, 2014
Robotic ureteral reconstruction distal to the ureteropelvic junction: a large single institution clinical series with short-term follow upGordon L Fifer, Mathew C Raynor, Patrick Selph, et al.
Urologic Oncology|July 7, 2009
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?Raj Kurpad, William Kim, W Kim Rathmell, et al.
BJU International|January 22, 2010
A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological resultsRaj S Pruthi, Matthew Nielsen, Samuel Heathcote, et al.
Urology|March 9, 2022
Virtual "Matchmaking": Stakeholder Perspectives on the Future of the Urology Residency MatchChristopher J Warren, Chanan R Reitblat, Charles A Ferreri, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Urology Practice|August 18, 2023
Advanced Practice Providers in U.S. Urology: A National Survey of Demographics and Clinical RolesJoshua P Langston, Venetia L Orcutt, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Pageof 22